Related references
Note: Only part of the references are listed.AML1-ETO inhibits acute myeloid leukemia immune escape by CD48
Zhiding Wang et al.
LEUKEMIA & LYMPHOMA (2021)
Tim-3 Promotes Listeria monocytogenes Immune Evasion by Suppressing Major Histocompatibility Complex Class I
Zhiding Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Acute myeloid leukemia immune escape by epigenetic CD48 silencing
Zhiding Wang et al.
CLINICAL SCIENCE (2020)
Natural killer cell-based immunotherapy for acute myeloid leukemia
Jing Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Cancer Epigenetics, Tumor Immunity, and Immunotherapy
Jian Cao et al.
TRENDS IN CANCER (2020)
Cellular therapy for acute myeloid Leukemia - Current status and future prospects
Panupong Hansrivijit et al.
BLOOD REVIEWS (2019)
Hypomethylating agents in the treatment of acute myeloid leukemia: A guide to optimal use
Valeria Santini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Acute myeloid leukemia and NK cells: two warriors confront each other
Aroa Baragano Raneros et al.
ONCOIMMUNOLOGY (2019)
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
Naval Daver et al.
LEUKEMIA (2018)
DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer
Na Luo et al.
NATURE COMMUNICATIONS (2018)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Molecular therapy for acute myeloid leukaemia
Catherine C. Coombs et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Repression of GSK3 restores NK cell cytotoxicity in AML patients
Reshmi Parameswaran et al.
NATURE COMMUNICATIONS (2016)
AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia
Lin Fu et al.
FEBS JOURNAL (2014)
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway
Yonghui Li et al.
BLOOD (2013)
MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
Patrizia Leone et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses
Li-Xin Wang et al.
PLOS ONE (2013)
Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study
H Kantarjian et al.
CANCER (2006)
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia
L Yu et al.
NATURE GENETICS (2005)
Share Paper
